Jung Shin Lee

Title: Jung Shin Lee: Innovator in Cancer Treatment

Introduction

Jung Shin Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, Lee's work focuses on enhancing the effectiveness of cancer therapies.

Latest Patents

One of his latest patents is a method for determining sensitivity to a simultaneous inhibitor against poly ADP ribose polymerase (PARP) and Tankyrase. This invention aims to maximize colorectal treatment effects by identifying patients who are sensitive to this combined inhibitor. Another notable patent is a composition for the treatment or metastasis suppression of cancers, which includes a p34 expression inhibitor or activity inhibitor as an active ingredient. This invention highlights the potential of p34 gene expression inhibitors in reducing the clonogenic and tumor-forming potential of various cancer cells.

Career Highlights

Jung Shin Lee has worked with reputable organizations, including the Asan Foundation and the University of Ulsan Foundation for Industry Cooperation. His career reflects a commitment to advancing cancer research and treatment methodologies.

Collaborations

Lee has collaborated with notable colleagues such as Dong Hoon Jin and Seung Woo Hong, contributing to the collective effort in cancer research and innovation.

Conclusion

Jung Shin Lee's contributions to cancer treatment through his patents and collaborations underscore his role as a key innovator in the field. His work continues to pave the way for advancements in cancer therapies.